Center-Authored Papers

Filters: Author is Press, Oliver  [Clear All Filters]
Journal Article
Gopal AK, Pagel JM, Fromm JR, Wilbur S, Press OW.  2009.  131I anti-CD45 radioimmunotherapy effectively targets and treats T-cell non-Hodgkin lymphoma.. Blood. 113(23):5905-10. Abstract
Pagel JM, Appelbaum FR, Eary JF, Rajendran J, Fisher DR, Gooley T, Ruffner K, Nemecek E, Sickle E, Durack L et al..  2006.  131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission.. Blood. 107(5):2184-91. Abstract
Hattori N, Gopal AK, Shields AT, Fisher DR, Gooley T, Pagel JM, Press OW, Rajendran JG.  2012.  131I-tositumomab myeloablative radioimmunotherapy for non-Hodgkin's lymphoma: radiation dose to the testes.. Nuclear medicine communications. 33(12):1225-31. Abstract
Matesan M, Rajendran J, Press OW, Maloney DG, Storb RF, Cassaday RD, Pagel JM, Oliveira G, Gopal AK.  2014.  90Y-ibritumomab tiuxetan therapy in allogeneic transplantation in B-cell lymphoma with extensive marrow involvement and chronic lymphocytic leukemia: utility of pretransplantation biodistribution.. Nuclear medicine communications. 35(11):1132-42. Abstract
Gopal AK, Guthrie KA, Rajendran J, Pagel JM, Oliveira G, Maloney DG, Matesan MC, Storb R, Press OW.  2011.  90Y-Ibritumomab tiuxetan, fludarabine, and TBI-based nonmyeloablative allogeneic transplantation conditioning for patients with persistent high-risk B-cell lymphoma.. Blood. 118(4):1132-9. Abstract
Wallen H, Gooley TA, Deeg HJ, Pagel JM, Press OW, Appelbaum FR, Storb R, Gopal AK.  2005.  Ablative allogeneic hematopoietic cell transplantation in adults 60 years of age and older.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 23(15):3439-46. Abstract
Till BG, Jensen MC, Wang J, Chen EY, Wood BL, Greisman HA, Qian X, James SE, Raubitschek A, Forman SJ et al..  2008.  Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells.. Blood. 112(6):2261-71. Abstract
Frankel AE, FitzGerald D, Siegall C, Press OW.  1996.  Advances in immunotoxin biology and therapy: a summary of the Fourth International Symposium on Immunotoxins.. Cancer research. 56(4):926-32.
Palanca-Wessels MC, Press OW.  2014.  Advances in the treatment of hematologic malignancies using immunoconjugates.. Blood. 123(15):2293-301. Abstract
Pagel JM, Gooley TA, Rajendran J, Fisher DR, Wilson WA, Sandmaier BM, Matthews DC, Deeg HJ, Gopal AK, Martin PJ et al..  2009.  Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome.. Blood. 114(27):5444-53. Abstract
Anderson JE, Litzow MR, Appelbaum FR, Schoch G, Fisher LD, Buckner CD, Petersen FB, Crawford SW, Press OW, Sanders JE.  1993.  Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 11(12):2342-50. Abstract
Frost SHL, Miller BW, Bäck TA, Santos EB, Hamlin DK, Knoblaugh SE, Frayo SL, Kenoyer AL, Storb R, Press OW et al..  2015.  Alpha Imaging Confirmed Efficient Targeting of CD45-Positive Cells after Astatine-211 (211At)-Radioimmunotherapy for Hematopoietic Cell Transplantation.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 56(11):1766-73. Abstract
Mostaghel EA, Martin PS, Mongovin S, Frayo S, Zhang A, Edlefsen KL, Press OW, Gopal AK.  2017.  Androgen Receptor Expression in Mantle Cell Lymphoma: Potential Novel Therapeutic Implications.. Experimental hematology.
Press OW, Rosse C, Clagett J.  1977.  Anti-brain antisera bind primarily to non-T cells in mouse bone marrow.. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.). 156(3):485-7.
Pfeifer M, Zheng B, Erdmann T, Koeppen H, McCord R, Grau M, Staiger A, Chai A, Sandmann T, Madle H et al..  2015.  Anti-CD22 and anti-CD79B antibody drug conjugates are active in different molecular diffuse large B-cell lymphoma subtypes.. Leukemia. Abstract
Palanca-Wessels MC, Convertine AJ, Cutler-Strom R, Booth GC, Lee F, Berguig GY, Stayton PS, Press OW.  2011.  Anti-CD22 Antibody Targeting of pH-responsive Micelles Enhances Small Interfering RNA Delivery and Gene Silencing in Lymphoma Cells.. Molecular therapy : the journal of the American Society of Gene Therapy. 19(8):1529-37. Abstract
Pagel JM, Kenoyer AL, Bäck T, Hamlin DK, Wilbur SD, Fisher DR, Park SI, Frayo S, Axtman A, Orgun N et al..  2011.  Anti-CD45 pretargeted radioimmunotherapy using bismuth-213: high rates of complete remission and long-term survival in a mouse myeloid leukemia xenograft model.. Blood. 118(3):703-11. Abstract
Orozco JJ, Bäck T, Kenoyer A, Balkin ER, Hamlin DK, Wilbur SD, Fisher DR, Frayo SL, Hylarides MD, Green DJ et al..  2013.  Anti-CD45 radioimmunotherapy using 211At with bone marrow transplantation prolongs survival in a disseminated murine leukemia model.. Blood. 121(18):3759-67. Abstract
Orozco JJ, Balkin ER, Gooley TA, Kenoyer A, Hamlin DK, Wilbur SD, Fisher DR, Hylarides MD, Shadman M, Green DJ et al..  2014.  Anti-CD45 radioimmunotherapy with 90Y but not 177Lu is effective treatment in a syngeneic murine leukemia model.. PloS one. 9(12):e113601. Abstract
Orozco JJ, Kenoyer A, Balkin ER, Gooley TA, Hamlin DK, Wilbur SD, Hylarides MD, Frost SHL, Mawad R, O'Donnell P et al..  2015.  Anti-CD45 radioimmunotherapy without TBI before BMT facilitates persistent haploidentical donor engraftment in a murine model.. Blood. Abstract
Palanca-Wessels MC, Booth GC, Convertine AJ, Lundy BB, Berguig GY, Press MF, Stayton PS, Press OW.  2016.  Antibody targeting facilitates effective intratumoral siRNA nanoparticle delivery to HER2-overexpressing cancer cells.. Oncotarget. Abstract
James SE, Orgun NN, Tedder TF, Shlomchik MJ, Jensen MC, Lin Y, Greenberg PD, Press OW.  2009.  Antibody-mediated B-cell depletion before adoptive immunotherapy with T cells expressing CD20-specific chimeric T-cell receptors facilitates eradication of leukemia in immunocompetent mice.. Blood. 114(27):5454-63. Abstract
James SE, Greenberg PD, Jensen MC, Lin Y, Wang J, Till BG, Raubitschek AA, Forman SJ, Press OW.  2008.  Antigen sensitivity of CD22-specific chimeric TCR is modulated by target epitope distance from the cell membrane.. Journal of immunology (Baltimore, Md. : 1950). 180(10):7028-38. Abstract
Shan D, Ledbetter JA, Press OW.  1998.  Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies.. Blood. 91(5):1644-52. Abstract
Park JM, Yang X, Park JJ, Press OW, Press MF.  1999.  Assessment of novel anti-p185HER-2 monoclonal antibodies for internalization-dependent therapies.. Hybridoma. 18(6):487-95. Abstract